Skip to main content
ELAB
NASDAQ Life Sciences

PMGC Subsidiary Files Patents for Muscle Preservation in Booming GLP-1 Market

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.48
Mkt Cap
$6.498M
52W Low
$1.34
52W High
$309.12
52W Position info
10% above low
Off High info
100% below high
Rel. Volume
Market data snapshot near publication time

ELAB is trading near its 52-week low of $1.34 (10% above the low).

Summary

PMGC Holdings' subsidiary, NorthStrive Biosciences, has filed two new U.S. patent applications for its EL-22 and EL-32 compounds. These filings strategically expand the company's intellectual property into human pharmaceutical applications, specifically targeting the preservation of lean muscle mass during GLP-1 and other obesity-related weight loss treatments. This move positions the micro-cap company in a high-growth and critical area within the booming GLP-1 market, addressing a known challenge of muscle loss during weight reduction. This product development news follows a series of significant dilutive financing events and an acquisition by PMGC Holdings, providing a strategic direction for the company's capital.

At the time of this announcement, ELAB was trading at $1.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.5M. The 52-week trading range was $1.34 to $309.12. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ELAB - Latest Insights

ELAB
Nov 02, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.12
Real-time Price: $1.60 info
Change: -$0.5196 (-25%) info
Market Cap: $1.336M info
ELAB
Oct 01, 2026, 8:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $3.62
Real-time Price: $1.60 info
Change: -$2.02 (-56%) info
Market Cap: $1.336M info
ELAB
Sep 18, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.70
Real-time Price: $1.60 info
Change: -$3.10 (-66%) info
Market Cap: $1.336M info
ELAB
Sep 02, 2026, 5:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.20
Real-time Price: $1.60 info
Change: -$3.60 (-69%) info
Market Cap: $1.336M info
ELAB
Sep 01, 2026, 7:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.23
Real-time Price: $1.60 info
Change: -$3.63 (-69%) info
Market Cap: $1.336M info